IDH1 and myeloid neoplasm: Elevated levels of 2-HG induce epigenetic remodeling by inhibiting TET2 and Jumonji C domain-containing histone demethylases, which is partially responsible for the differentiation blockade seen in IDH-mutated myeloid malignancies [95, 96].